Terms: = Liver cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Prognosis
56 results:
1. The GRAPHS-CRAFITY score: a novel efficacy predictive tool for unresectable hepatocellular carcinoma treated with immunotherapy.
Yang Y; Li L; Xu Y; Ouyang J; Zhou Y; Ye F; Huang Z; Zhang W; Zhou A; Zhao X; Cai J; Wang Y; Zhou J; Zhao H
Radiol Med; 2024 Feb; 129(2):188-201. PubMed ID: 38180570
[TBL] [Abstract] [Full Text] [Related]
2. High Tumor Uptake on
De Rycke O; Perrier M; Ouvrard É; Mennetrey C; Lachachi C; Bando-Delaunay A; Morland D; Goichot B; Taieb D; Walter T; Cadiot G; Cros J; Hentic O; Ruszniewski P; Lebtahi R; Imperiale A; de Mestier L
J Nucl Med; 2023 Nov; 64(11):1699-1705. PubMed ID: 37652547
[TBL] [Abstract] [Full Text] [Related]
3. prognosis of repeat hepatectomy for liver transplantable hepatocellular carcinoma recurrence after hepatectomy: a Retrospective Cohort Study with the Hiroshima Surgical Study Group of Clinical Oncology (HiSCO).
Ohira M; Kobayashi T; Hamaoka M; Abe T; Onoe T; Inoue M; Honmyo N; Oishi K; Ohdan H;
Langenbecks Arch Surg; 2023 Aug; 408(1):314. PubMed ID: 37584772
[TBL] [Abstract] [Full Text] [Related]
4. Comparison of Baseline
Wu M; Wang Y; Yang Q; Wang X; Yang X; Xing H; Sang X; Li X; Zhao H; Huo L
J Nucl Med; 2023 Oct; 64(10):1532-1539. PubMed ID: 37500263
[TBL] [Abstract] [Full Text] [Related]
5. Stacking Ensemble Learning-Based [
Zhao S; Wang J; Jin C; Zhang X; Xue C; Zhou R; Zhong Y; Liu Y; He X; Zhou Y; Xu C; Zhang L; Qian W; Zhang H; Zhang X; Tian M
J Nucl Med; 2023 Oct; 64(10):1603-1609. PubMed ID: 37500261
[TBL] [Abstract] [Full Text] [Related]
6. Risk Factors of Positive Resection Margin in Hepatectomy for Resectable Ruptured Hepatocellular Carcinoma: Risk Prediction and prognosis.
Xia F; Zhang Q; Zheng J; Huang Z; Ndhlovu E; Gao H
J Gastrointest Surg; 2023 Jul; 27(7):1400-1411. PubMed ID: 37095336
[TBL] [Abstract] [Full Text] [Related]
7. Primary tumor SUV
Tas F; Ozturk A; Erturk K
Wien Klin Wochenschr; 2023 Sep; 135(17-18):478-487. PubMed ID: 36882606
[TBL] [Abstract] [Full Text] [Related]
8. The added value of [
Liu Q; Shi S; Liu S; Xu X; Hu S; Zhang J; Wang C; Yu X; Song S
Eur Radiol; 2023 Jul; 33(7):5007-5016. PubMed ID: 36809431
[TBL] [Abstract] [Full Text] [Related]
9. Prospective Phase II Trial of [
Carlsen EA; Loft M; Loft A; Czyzewska D; Andreassen M; Langer SW; Knigge U; Kjaer A
J Nucl Med; 2023 Feb; 64(2):252-259. PubMed ID: 35981899
[TBL] [Abstract] [Full Text] [Related]
10.
Wei A; Lu X; Ma H; Lian H; Yang X; Zhang L; Wang D; Chen S; Zhang Q; Li Z; Zhang R; Yang J; Wang T
Contrast Media Mol Imaging; 2022; 2022():4849081. PubMed ID: 35510179
[TBL] [Abstract] [Full Text] [Related]
11. Prospective Phase II Trial of Prognostication by
Carlsen EA; Loft M; Loft A; Berthelsen AK; Langer SW; Knigge U; Kjaer A
J Nucl Med; 2022 Sep; 63(9):1371-1377. PubMed ID: 35058319
[TBL] [Abstract] [Full Text] [Related]
12. [Prognostic evaluation value of (18)F-FDG PET-CT in Hodgkin's lymphoma after treatment].
Wan H; Liu P; Liang Y; Jiang SY; Lyu L; Zhang ZW; Wu N; Liu Y
Zhonghua Zhong Liu Za Zhi; 2021 Dec; 43(12):1275-1281. PubMed ID: 34915636
[No Abstract] [Full Text] [Related]
13. The Role of FDG-PET and Whole-Body MRI in High Grade Bone Sarcomas With Particular Focus on Osteosarcoma.
Farina A; Gasperini C; Aparisi Gómez MP; Bazzocchi A; Fanti S; Nanni C
Semin Nucl Med; 2022 Sep; 52(5):635-646. PubMed ID: 34879906
[TBL] [Abstract] [Full Text] [Related]
14. The Value of
Yoon HY; Lee SH; Ha S; Ryu JS; Song JW
J Korean Med Sci; 2021 Oct; 36(41):e257. PubMed ID: 34697928
[TBL] [Abstract] [Full Text] [Related]
15. PPM1G promotes the progression of hepatocellular carcinoma via phosphorylation regulation of alternative splicing protein SRSF3.
Chen D; Zhao Z; Chen L; Li Q; Zou J; Liu S
Cell Death Dis; 2021 Jul; 12(8):722. PubMed ID: 34290239
[TBL] [Abstract] [Full Text] [Related]
16. Combined prognostic nutritional index and albumin-bilirubin grade to predict the postoperative prognosis of HBV-associated hepatocellular carcinoma patients.
Liang X; Liangliang X; Peng W; Tao Y; Jinfu Z; Ming Z; Mingqing X
Sci Rep; 2021 Jul; 11(1):14624. PubMed ID: 34272447
[TBL] [Abstract] [Full Text] [Related]
17. Effect of timing of surgical resection of primary hepatocellular carcinoma on survival outcomes in elderly patients and prediction of clinical models.
He Y; Liang T; Mo S; Chen Z; Zhao S; Zhou X; Yan L; Wang X; Su H; Zhu G; Han C; Peng T
BMC Gastroenterol; 2021 May; 21(1):230. PubMed ID: 34020603
[TBL] [Abstract] [Full Text] [Related]
18. Elevated Postoperative Levels of Serum C-reactive Protein Are Associated With Shorter Long-term Survival After Resection of Colorectal liver Metastases, Regardless of the Occurrence of Infectious Complications.
Shibutani M; Kimura K; Kashiwagi S; Wang EN; Okazaki Y; Maeda K; Hirakawa K; Ohira M
Anticancer Res; 2021 May; 41(5):2605-2610. PubMed ID: 33952490
[TBL] [Abstract] [Full Text] [Related]
19. Nurse coordinator roles in the management of patients with hepatocellular carcinoma: A French national survey.
Devictor J; Leclercq A; Hazo JB; Burnet E; Jovic L; Bouattour M; Ganne-Carrié N
Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101650. PubMed ID: 33609787
[TBL] [Abstract] [Full Text] [Related]
20. Clinical features and diagnostic imaging of cholangiolocellular carcinoma compared with other primary liver cancers: a surgical perspective.
Takamura H; Gabata R; Obatake Y; Nakanuma S; Hayashi H; Kozaka K; Sasaki M; Okazaki M; Yamaguchi T; Shimbashi H; Terai S; Okamoto K; Makino I; Kinoshita J; Nakamura K; Miyashita T; Tajima H; Ninomiya I; Fushida S; Kitao A; Kitahara M; Arai K; Yamashita T; Yamashita T; Ikeda H; Satoh Y; Harada K; Kaneko S; Gabata T; Kosaka T; Ohta T
Technol Cancer Res Treat; 2020; 19():1533033820948141. PubMed ID: 33073719
[TBL] [Abstract] [Full Text] [Related]
[Next]
